This Manchester business makes genetic testing kits used to diagnose conditions such as cystic fibrosis. It sells to hospitals and clinics in 19 countries and generated £2.2m turnover last year. The business was founded 20 years ago by pharmaceutical giant AstraZeneca and has changed hands several times since. In October 2013 the business was established as an independent company, when Scott Higgins, 55, and Mike Webb, 60, led a management buyout backed by Percipient Capital. The investment will enable Elucigene to move to a new manufacturing site at Manchester University Hospital. The company plans to expand internationally and sees South America and India as key markets for its growth.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.